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Abstract By incubating 32P-labelled adipocytes, and extracts
from these cells, in the presence or absence of specific inhibitors,
we evaluated the contribution of protein phosphatases PP1,
PP2A and PP2C, to the dephosphorylation of perilipin, an
acutely hormone-regulated adipocyte phosphoprotein. Under
conditions to completely inhibit PP2A activity, perilipin
phosphatase activity in extracts remain unaffected, but PP1
inhibition results in abolition of perilipin phosphatase activity.
Inhibition of PP1 (and 2A) in intact adipocytes stimulated
lipolysis and increased phosphorylation of perilipin. No involve-
ment of PP2C was found. Hence, PP1 constitutes the
predominant if not sole perilipin phosphatase in adipocytes.
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1. Introduction
The rate-limiting step of adipose tissue lipolysis is catalysed
by hormone-sensitive lipase (HSL), an enzyme that is acutely
regulated by hormones that elevate cAMP and activate
cAMP-dependent protein kinase (PKA) (reviewed in [1,2]).
It has been widely accepted that on stimulation of lipolysis
in adipocytes by catecholamines [3], speci¢c serine phosphor-
ylation of the ‘regulatory site’ (Ser-563) or site 1 of HSL by
PKA occurs [4]. A further ‘basal site’ (Ser-565), or site 2 of
HSL, is phosphorylated in vivo [4], but it is not yet clear
under which conditions, if any, its extent of phosphorylation
changes. Subsequently two further PKA phosphorylation
sites, Ser-659 and Ser-660, have been discovered [5]. Insulin,
which exerts anti-lipolytic e¡ects by both cAMP-dependent
and -independent mechanisms not yet fully understood [6],
inhibits HSL via dephosphorylation of the enzyme, possibly,
in part, by stimulating a phosphatase activity [7]. However, it
is evident that lipolytic regulation is not due to HSL reversible
phosphorylation alone, as there exists a discrepancy between
the degree of activation of HSL in vitro (2^3-fold) and of the
extraordinary stimulation of lipolysis observed in the intact
cell (50^100-fold) [8,9]. This discrepancy may be underlined,
at least in part, by the discovery that on lipolytic stimulation,
HSL alters its subcellular localisation [10], and has been
shown to translocate onto the lipid droplet [11].
Perilipins are proteins tightly associated with the surface of
lipid storage droplets in adipocytes, and are highly phos-
phorylated by PKA on lipolytic stimulation, in concert with
the activation of HSL (reviewed in [12]). Current evidence
suggests that the perilipins not phosphorylated by PKA pro-
vide a barrier against hydrolysis by neutral lipid lipases, and
this barrier is removed upon phosphorylation by PKA ([13],
C. Londos, unpublished data).
In response to insulin, the degree of perilipin phosphoryla-
tion is decreased, and it has been suggested that insulin, in
addition to lowering cAMP levels, may also stimulate a peril-
ipin phosphatase activity [14]. In a previous study from this
laboratory, it was shown that adipocytes contain signi¢cant
levels of both protein phosphatase 1 (PP1) and 2A (PP2A)
(1.6 and 2.0 mU/ml packed cells respectively), with lower lev-
els of PP2C and virtually no PP2B activity. PP2A and PP2C
were shown to exhibit similar degrees of activity against HSL
phosphorylated at the regulatory site, whereas the basal site is
dephosphorylated predominantly by PP2A (over 50% of total
activity), with PP1 and PP2C constituting the rest of the ac-
tivity against this site [15]. There is, as yet, no published in-
formation on the phosphatases that may be acting on the two
recently discovered phosphorylation sites on HSL.
In the present study we examine directly the dephosphor-
ylation of perilipin, both in intact adipocytes and in extracts
of lipolytically stimulated cells, in the presence or absence of
various speci¢c inhibitors. The identi¢ed perilipin phospha-
tase activity, namely PP1, has previously been shown to be
activated in adipocytes in response to insulin [16], and we
discuss the possibility that insulin may be mediating some of
its anti-lipolytic e¡ects via stimulation of PP1 and dephos-
phorylation of perilipin.
2. Materials and methods
2.1. Materials
[32P]Orthophosphate was purchased from ICN. The protease inhib-
itors pepstatin, leupeptin and antipain were from the Peptide Institute,
Osaka, Japan. Collagenase was from Worthington Biochemical Cor-
poration, NY, USA. Puri¢ed catalytic subunits of protein phospha-
tases 1 and 2A, and inhibitor 2 (I-2) were purchased from Boehringer
Mannheim, Lewes, UK. Okadaic acid (OA) was obtained from Cal-
biochem, and all other chemicals were from Sigma, Poole, UK. Anti-
perilipin NH2-terminal antibody was raised in rabbits as described
previously [17]. Male Wistar rats, fed ad libitum on a diet of standard
laboratory chow, were raised in house at the Hannah Research In-
stitute, or the Comparative Biology Centre at the University of New-
castle upon Tyne.
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2.2. Adipocyte isolation
Adipocytes were isolated by collagenase digestion of epididymal fat
pads from 180^200 g male Wistar rats killed by cervical dislocation, as
described in [18]. All manipulations of adipocytes were performed in
reduced phosphate (50 WM KH2PO4) Krebs-Ringer solution at 37‡C,
bu¡ered with 25 mM HEPES pH 7.4 containing 2.5 mM CaCl2, and
1% bovine serum (reduced phosphate KRH or red. Pi KRH). 200 nM
adenosine was included to suppress cAMP production and stimula-
tion of cAMP-dependent protein kinase activity [19]. Following iso-
lation, cells were shaken at 37‡C for 1 h, to allow the intracellular
cAMP to return to basal levels. Cells were then washed in BSA-free
red. Pi KRH supplemented with 200 nM adenosine. The packed cell
volume (PCV) of the ¢nal suspension was determined by aspirating
small aliquots into capillary haematocrit tubes and spinning in a mi-
crohaematocrit centrifuge.
2.3. Estimation of glycerol release
Aliquots of 20 Wl were withdrawn from agitated incubations of cells
at 200 Wl cells/ml PCV, and added to 200 Wl GPO-Trinder reagent
(Sigma Diagnostics). This procedure was a modi¢cation of the meth-
od in [20]. Glycerol release is expressed as nmol glycerol/ml PCV.
2.4. 32P Labelling of adipocytes
Adipocytes (200 Wl PCV/ml) were loaded with [32P]Pi, by incubating
the cells in BSA free red. Pi KRH supplemented with 200 nM adeno-
sine and 200 WCi/ml [32P]Pi for 1 h in a shaking water bath at 37‡C.
32P-Labelled adipocytes were either incubated under ‘basal’ condi-
tions, lipolytically stimulated with 100 nM isoproterenol and 1 U/ml
adenosine deaminase or incubated in the presence of various concen-
trations of OA, for the indicated length of time.
2.5. Preparation of 32P-labelled adipocyte extracts
Adipocytes were allowed to £oat to the surface and the infranatant
containing the [32P]Pi was removed by aspiration with a syringe. The
remaining adipocytes were lysed with ice-cold 50 mM Tris-HCl bu¡er
pH 7.4 containing 225 mM sucrose, 1 mM EDTA, 1 mM benzami-
dine, 1 Wg/ml of pepstatin, 1 Wg/ml leupeptin, 1 Wg/ml antipain, (bu¡er
B). For the preparation of extracts in which perilipin phosphatase
activity was to be estimated, bu¡er B was supplemented with 3%
Triton N-101. For the analysis of the phosphorylation state of peril-
ipin in the intact cell, bu¡er B was supplemented with 1% Triton N-
101 and 50 mM NaF to inhibit phosphatase activity in the extract.
The lysate was then vortexed vigorously and centrifuged at 13 000Ug
for 5 min at 4‡C. Solubilised protein extract was then aspirated from
under the solidi¢ed lipid fraction and kept on ice.
2.6. Estimation of perilipin dephosphorylation in extracts
32P-Labelled extracts containing 3% Triton, prepared for the esti-
mation of perilipin phosphatase activity, were diluted 1:3 in bu¡er B
containing inhibitors or other additions to give the ¢nal concentra-
tions indicated in the text. These diluted extracts were then incubated
for up to 120 min at 37‡C with shaking, and samples were removed
into an equal volume of Laemmli sample bu¡er for SDS-PAGE. 32P-
Labelled extracts containing 1% Triton and 50 mM NaF prepared
from intact cells treated with or without inhibitors were added imme-
diately to an equal volume of Laemmli sample bu¡er for SDS-PAGE.
2.7. SDS-PAGE and Western blot analysis
SDS-PAGE was performed [21] using a Tris/glycine bu¡er system
with Hoe¡er mini-gel apparatus. For Western blotting, protein sam-
ples subjected to SDS-PAGE were transferred onto polyvinylidene
di£uoride (PVDF) membranes, probed with anti-perilipin antibodies,
and the amount of perilipin determined by Enhanced Chemilumines-
cence reagents from Amersham, UK. Proteins subjected to SDS-
PAGE were stained with Coomassie blue R, and phosphoproteins
were visualised by exposure to Fuji ¢lm. The loss of 32P from the
prominent 66 kDa band was estimated by digitalisation with a Fuji
BAS-1500 phosphorimager.
3. Results
3.1. Characterisation of perilipin phosphatase activity
in adipocyte extracts
Preliminary experiments con¢rmed the presence of a pre-
dominant 66 kDa phosphoprotein in 32P-labelled lipolytically
stimulated adipocyte extracts as reported previously [14]. The
band was identi¢ed as perilipin by Western blotting with an
antibody raised against a perilipin NH2-terminal recombinant
peptide (Fig. 1). Furthermore, the radioactive polypeptide co-
puri¢ed with perilipin (detected by Western blotting) through
several puri¢cation steps (not shown). Incubation of extracts
at 37‡C resulted in a signi¢cant loss of 32P label from this
band, over a time course of up to 120 min. It was estimated
that the rate of loss of 32P label from perilipin was approx-
imately linear over the ¢rst 40 min of incubation under these
conditions, which was the maximal length of incubation used
in subsequent experiments. There was negligible proteolysis of
extract proteins under these conditions as estimated by Coo-
massie blue R staining of the polyacrylamide gels (not shown).
Furthermore, immunoreactivity of the 66 kDa band did not
decrease during this period, indicating that proteolysis of per-
ilipin was not occurring (Fig. 1). Thus, this loss of radiolabel
from the 66 kDa polypeptide was attributed to the dephos-
phorylation of perilipin, due to an endogenous phosphatase
activity present in adipocyte extracts.
3.2. Identi¢cation of protein phosphatases acting on perilipin
Over the 40 min of incubation, endogenous perilipin phos-
phatase activity accounted for the loss of approximately 44%
of the 32P label from perilipin. This was classi¢ed as 100%
endogenous activity in subsequent experiments. On addition
of 50 mM NaF, a potent non-speci¢c phosphatase inhibitor,
all phosphatase activity was abolished. (This observation also
constitutes indirect evidence that no proteolysis is taking
place.) Similarly, addition of OA, a speci¢c inhibitor of PP1
and PP2A, to a concentration of 1 WM almost entirely elim-
inated the perilipin phosphatase activity, 99% of the 32P label
remaining incorporated in perilipin. The inclusion of Mg2
(required for the activation of PP2C), in the presence of
1 WM OA, caused no signi¢cant change of perilipin phospha-
tase activity over that in the presence of 1 WM OA alone.
Further, the inclusion of Mg2 alone in the incubation bu¡er
resulted in no statistically signi¢cant di¡erence in endogenous
perilipin phosphatase activity, which indicates that PP2C is
not a signi¢cant perilipin phosphatase. The degree of perilipin
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Fig. 1. Identi¢cation of 66 kDa phosphoprotein in adipocyte ex-
tracts as perilipin. A: Protein molecular weight markers. B: Phos-
phorimage of extract from 32P-labelled adipocytes in the absence of
any additions, after 0, 10, 20, and 40 min of incubation at 37‡C.
C: Western blot of extract from adipocytes after 0, 10, 20, and
40 min of incubation at 37‡C, probed with an a⁄nity-puri¢ed anti-
body raised against an NH2-terminal peptide of perilipin A (all 10%
SDS gels).
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dephosphorylation under these various conditions is shown in
Table 1.
The inclusion of OA, a speci¢c inhibitor of PP1 and PP2A,
with IC50 values of 15 nM and 6 0.1 nM respectively, had an
inhibitory e¡ect on the endogenous perilipin activity present
in the extracts. The addition of 2 nM OA, a concentration at
which the activity of PP2A would be expected to be over 90%
inhibited [15], had no signi¢cant e¡ect on perilipin dephos-
phorylation. Further increases to the OA concentration, re-
sulted in a decrease in the perilipin phosphatase activity in a
dose-dependent manner, with an IC50 of about 12 nM. Fi-
nally, as noted in Section 3.1, inclusion of OA at a concen-
tration of 1 WM resulted in the almost total abolition of peril-
ipin phosphatase activity (Fig. 2A).
Similarly, on increasing the concentration of I-2, a speci¢c
inhibitor of PP1, a dose-responsive decrease in the perilipin
phosphatase activity was observed, with an IC50 of about
10 nM. On addition of 100 nM I-2, approximately 70% of
the endogenous activity was lost (Fig. 2B). In Fig. 2A,B, the
inhibitory e¡ects of OA and I-2 on perilipin phosphatase ac-
tivity are compared to the e¡ects previously observed in this
laboratory, on the phosphorylase a phosphatase activity of
PP1 and PP2A. These activities were estimated by the release
of 32P from 32P-labelled phosphorylase a by the endogenous
PP1 and PP2A present in adipocyte extracts.
These ¢ndings indicate that PP1 is responsible for perilipin
dephosphorylation in adipocyte extracts. This is supported by
further incubations of 32P-labelled extracts, in which the ac-
tivity of each of these phosphatases was increased by the in-
clusion of additional puri¢ed subunits of the phosphatases.
Inclusion of an excess of the catalytic subunit of PP1 (PP1c)
resulted in an observed increase of phosphatase activity
against perilipin, in a dose-responsive manner. No statistically
signi¢cant increase in perilipin phosphatase activity was ob-
served on inclusion of an equivalent excess of PP2Ac (data
not shown).
3.3. E¡ect of OA on lipolytic rate and the phosphorylation
state of perilipin in intact adipocytes
Since the cell is permeable to OA it can be used to inhibit
phosphatases in the intact adipocyte. It has been shown pre-
viously [22] that incubation of adipocytes with 1 WM OA,
which is su⁄cient to inhibit PP1 and 2A but not 2B and
2C, increases dramatically the phosphorylation state of
many proteins. In this study, the e¡ect of OA on the phos-
phorylation of perilipin in the intact adipocyte was investi-
gated (Fig. 3). Cells incubated in the absence of OA or iso-
proterenol remained in basal lipolytic state, with minimal
glycerol release. Inclusion of 1 WM OA resulted in a signi¢cant
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Fig. 3. E¡ect of OA on glycerol release and phosphorylation of per-
ilipin in intact adipocytes. 32P-Labelled adipocytes were prepared as
described in Section 2, and incubated for 10 min at 37‡C either
under basal conditions, in the presence of 100 nM isoproterenol and
1 U/ml ADA (stimulated), or in the presence of 1 nM or 1 WM
okadaic acid. Solid bars represent the glycerol release from intact
adipocytes over the 10 min of incubation, assayed as described in
Section 2, expressed as nmol of glycerol released per ml of packed
cells per minute. Hatched bars represent the phosphorylation state
of perilipin after the 10 min of incubation, estimated by phosphor-
image analysis of 32P-labelled perilipin after SDS-PAGE, expressed
as percentage of perilipin phosphorylation under basal conditions.
Both sets of data are presented as mean þ S.E.M. (n = 4).
Fig. 2. E¡ects of OA and I-2 on the perilipin phosphatase activity of adipocyte extracts. 32P-Labelled adipocyte extracts were prepared as de-
scribed in Section 2, and incubated for 40 min at 37‡C (A) in the presence of increasing concentrations of OA or (B) in the presence of increas-
ing concentrations of I-2. After 40 min of incubation extracts were subjected to SDS-PAGE, and phosphorimaged as described in Section 2.
Results are presented as a percentage of the endogenous activity in the absence of inhibitors, þ S.E.M. (A, n = 2^7; B, n = 3). Data are com-
pared against the e¡ects of the two inhibitors on PP1 and PP2A phosphatase activity in adipocyte extracts as in Wood et al. [15], using phos-
phorylase a as a substrate.
Table 1
Perilipin dephosphorylation in adipocyte extracts
Incubation conditions Loss of 32P label from perilipin (%)
No additions (endogenous) 43.7 þ 2.1 (100)
50 mM NaF 30.8 þ 2.8 (31.9 þ 6.5)
1 WM OA 1.1 þ 2.8 (2.4 þ 6.4)*
1 WM OA+20 mM Mg2 6.1 þ 2.4 (13.9 þ 5.4)*
20 mM Mg2 39.7 þ 1.7 (90.8 þ 4.0)
Extracts were incubated for 40 min at 37‡C, with or without additions
shown. Data are presented as means þ S.E.M. (n = 4^10). Numbers in
parentheses refer to loss of 32P label as percentage of control. *Not
signi¢cantly di¡erent, Ps 0.1.
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increase in glycerol release (P6 0.05), representing a 3.4-fold
increase in lipolysis. This compares to a 4.5-fold increase in
lipolysis by stimulation with 100 nM isoproterenol (P6 0.05).
Phosphorimage analysis of extracts from these cells revealed
that inclusion of 1 WM OA resulted in a signi¢cant increase
(P6 0.05) in the phosphorylation state of perilipin, 2.7-fold
over that under basal conditions, which compares with a 1.9-
fold increase in the phosphorylation of perilipin by stimula-
tion with isoproterenol (Fig. 3). These ¢ndings support the
role of PP1 in being responsible for dephosphorylation of
perilipin and indicate that 2B and 2C are not involved. Lower
levels of OA were without signi¢cant e¡ect on lipolysis or
perilipin phosphorylation suggesting PP2A is not involved,
although due to the uncertainty over the intracellular concen-
tration of PP2A in adipocytes, this cannot be ¢rmly estab-
lished.
4. Discussion
In contrast to the amount known about perilipin phosphor-
ylation by cAMP-dependent kinase in response to catechol-
amines [14], relatively little is known about the mechanism by
which it is dephosphorylated. Londos et al. ¢rst showed that
insulin counteracted the isoproterenol e¡ect of 32P incorpora-
tion into perilipin, by a mechanism independent of insulin’s
ability to lower cAMP levels [6]. Thus, it has been suggested
that insulin mediates its e¡ects, at least in part, by activating a
speci¢c serine phosphatase. Although perilipin has several pu-
tative phosphorylation sites as identi¢ed from the primary
sequence [23], the phosphorylation state of speci¢c sites
have not been studied. Hence, only the global phosphoryla-
tion state, and subsequent dephosphorylation can be studied.
The evidence presented here indicates that dephosphoryla-
tion of perilipin in adipocytes is mediated via PP1. The inclu-
sion in extracts of OA at concentrations which would be ex-
pected to inhibit s 90% of PP2A activity, leaving that of PP1
una¡ected, had no e¡ect on the dephosphorylation of peril-
ipin. Thus it would seem that PP2A plays no signi¢cant part
in the dephosphorylation of perilipin. Furthermore, increasing
the concentration of OA to levels which would be expected to
increasingly inhibit the activity of PP1, resulted in inhibition
of perilipin phosphatase activity. Inclusion of OA at 1 WM, a
concentration at which PP1 and PP2A activity is fully inhib-
ited, resulted in the abolition of the perilipin phosphatase
activity in adipocyte extracts. 1 WM OA was also found to
increase the phosphorylation state of perilipin in intact adipo-
cytes in concert with the stimulation of lipolysis, o¡ering evi-
dence that inhibition of PP1 (or PP2A) activity increases peril-
ipin phosphorylation, presumably on those sites
phosphorylated by PKA, and mimics the stimulation of
lipolysis by PKA in vivo.
More evidence for the role of PP1 was gathered by incubat-
ing extracts in the presence of I-2, a speci¢c cytosolic inhibitor
of PP1 [24]. The addition of increasing concentrations of I-2
resulted in the decrease of perilipin phosphatase activity in a
concentration-dependent manner. On comparison of the I-2
inhibitory e¡ects on the perilipin phosphatase activity with
those previously observed in this laboratory, we observe a
Ki for I-2 of about 80% that previously determined for I-2,
estimated by release of 32P from 32P-labelled phosphorylase a
by PP1 in adipocyte extracts, and puri¢ed PP1c. This shortfall
in the ability of I-2 to inhibit perilipin phosphatase activity
compared with PP1 may be a function of the protocol used or
substrate speci¢city, i.e. perilipin as opposed to phosphorylase
a. It has been noted previously that I-2 can have di¡erent
e¡ects on the kinetics of dephosphorylation of distinct sub-
strates of PP1 [25]. No evidence was obtained for a signi¢cant
contribution of PP2C to the dephosphorylation of perilipin.
Several researchers have reported that PP1 in 3T3-L1 adi-
pocytes is stimulated by the action of insulin [26,27], but
whether this is via the mechanism reported in skeletal muscle
has yet to be determined [28]. The data presented from this
study are supported by the observations of Misek and Saltiel
who, in studying the insulin-mimicking e¡ects of glycosyl
phosphatidylinositols, showed that these compounds inhibited
isoproterenol stimulated lipolysis in intact rat adipocytes, and
blocked the phosphorylation of a 70 kDa phosphoprotein in
the cytosol of these cells, via the activation of a PP1 activity
[29]. However, only a small proportion of this phosphoprotein
was found in the cytosol, being almost entirely lipid-associ-
ated, and is likely to correspond to perilipin, although there is
no evidence in direct support of this. Taken together, the data
are consistent with PP1 being involved in the insulin-mediated
dephosphorylation of perilipin, in that it has been demon-
strated that PP1 can be activated by insulin in intact adipo-
cytes [16], that perilipin can be dephosphorylated by PP1
(present work) and that perilipin is dephosphorylated in re-
sponse to insulin [14]. De¢nitive proof, however, will need to
come from a cell model lacking PP1 activity.
Evidence to date indicates that HSL and perilipin are phos-
phorylated and dephosphorylated in parallel under a variety
of conditions. However, the current and previous data indi-
cate that the regulation of the phosphorylation state of the
two proteins di¡er in that the phosphorylation state of peril-
ipin can apparently be accounted for by two proteins, namely
PKA and PP1, whereas HSL is subject to control by addi-
tional kinases and phosphatases, the speci¢c role of which has
yet to be clari¢ed.
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